TECX
NASDAQ · Biotechnology
Tectonic Therapeutic Inc
$28.03
-0.48 (-1.68%)
Open$28.47
Previous Close$28.51
Day High$28.60
Day Low$27.24
52W High$39.53
52W Low$14.39
Volume—
Avg Volume148.0K
Market Cap582.11M
P/E Ratio—
EPS$-4.46
SectorBiotechnology
Analyst Ratings
Strong Buy
16 analysts
Price Target
+32.8% upside
Current
$28.03
$28.03
Target
$37.23
$37.23
$31.47
$37.23 avg
$57.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 64.42M | 64.45M | 57.14M |
| Net Income | 9.98M | 8.55M | 7.27M |
| Profit Margin | 15.5% | 13.3% | 12.7% |
| EBITDA | 14.26M | 12.01M | 10.46M |
| Free Cash Flow | 6.92M | 8.94M | 6.74M |
| Rev Growth | +22.9% | -2.6% | -4.3% |
| Debt/Equity | 0.17 | 0.17 | 0.14 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |